Circle Pharma Appoints Alan Ashworth, PhD, FRS and Bruce Stillman, PhD, FRS to Its SAB Epsilon09242023-07-19T07:06:48-07:00October 21, 2020|Press Releases|
Circle Pharma Appoints Rajinder Singh, PhD as its Chief Science Officer Epsilon09242023-07-19T07:07:12-07:00July 20, 2020|Press Releases|
Circle Pharma Appoints William G. Kaelin Jr. MD as Chair of Its Scientific Advisory Board Epsilon09242023-07-19T07:07:46-07:00May 27, 2020|Press Releases|
Circle Pharma raises $45 Million in Series B Financing Epsilon09242023-07-19T07:08:40-07:00March 17, 2020|Press Releases|
Circle Pharma Congratulates Dr. William G. Kaelin, Jr., MD on Award of Nobel Prize Epsilon09242023-07-19T07:09:38-07:00October 9, 2019|Press Releases|
Circle Pharma Announces Publication in Journal of Medicinal Chemistry of Results from Collaboration with Pfizer Inc. Epsilon09242023-07-19T07:10:06-07:00January 17, 2018|Press Releases|
Circle Pharma Announces Appointment of David Spellmeyer, PhD, as Chief Scientific Officer Epsilon09242023-07-19T07:10:34-07:00November 20, 2017|Press Releases|
Circle Pharma announces expansion of Series A financing and appointment of James C. Lu to its board Epsilon09242023-07-19T07:11:03-07:00April 25, 2017|Press Releases|
Circle Pharma announces Series A financing and appoints Walter H. Moos, Ph.D., to its board Epsilon09242023-07-19T07:11:27-07:00December 21, 2016|Press Releases|
Circle Pharma enters into an agreement with Pfizer to build screening library of macrocyclic peptides Epsilon09242023-07-19T07:12:00-07:00September 12, 2016|Press Releases|
